New Market Study Published: Saudi Arabia Pharmaceuticals & Healthcare Report Q4 2013
Saudi Arabia will continue to attract the interest of foreign pharmaceutical companies, and not just that of multinationals. An increase in the number of joint venture (JV) agreements with local partners shows that generic drug-based foreign players are also targeting the rising demand for a range of medical treatments. Healthcare modernisation and facility expansion should further support this increasing demand, which is already being driven by epidemiological factors.
View full press release